Examination of our PC cohort indicated a trend of higher ING3 levels in samples with higher (7 or above) Gleason scores compared with samples with Gleason scores below 7 (Fig. 5b), and similar results were seen using TCGA prostate cohort data (not shown). This evidence concerns the gene ING3 and pachyonychia congenita.